Max Reinhardt - 02 Jul 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
President, Rest of World
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
02 Jul 2021
Transactions value $
-$25,159
Form type
4
Date filed
06 Jul 2021, 18:14
Previous filing
11 Jun 2021
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$25.2K -421 -2.35% $59.76 17.5K 02 Jul 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.